In 2023, Iceland leads with 33.26% of its scientific publications in cellular and molecular neuroscience ranking among the world's top 10% most-cited. Lithuania follows with 32.4%, while Cyprus and Malta achieve 27.56% and 25.6%, respectively. Notably, larger countries like the United States and China, despite their vast research output, show relatively moderate percentages of 10.16% and 11.41%. Consistently high performance from smaller nations highlights their strong focus on impactful research in this field.
Future trends to watch include how increased international collaboration, the rapid growth of emerging research hubs, and potential shifts in funding priorities can affect the distribution of top-cited publications globally. Enhanced global cooperation and advancements in technology might further democratize high-impact research output, possibly leading to changes in the current rankings.
Top countries in Share of Scientific Publications Among the World's 10% Top-Cited Publications in Cellular and Molecular Neuroscience by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Iceland | 33.26 | 2023 | View data |
| 2 | 2 Lithuania | 32.4 | 2023 | View data |
| 3 | 3 Cyprus | 27.56 | 2023 | View data |
| 4 | 4 Malta | 25.6 | 2023 | View data |
| 5 | 5 Saudi Arabia | 24.16 | 2023 | View data |
| 6 | 6 Ireland | 21.45 | 2023 | View data |
| 7 | 7 Singapore | 20.29 | 2023 | View data |
| 8 | 8 Indonesia | 18.15 | 2021 | View data |
| 9 | 9 Latvia | 17.46 | 2023 | View data |
| 10 | 10 Denmark | 17.13 | 2023 | View data |
